Human Papillomavirus (HPV) Vaccine Safety
Every year in the United States, about 11,000 women are diagnosed with cervical cancer and almost 4,000 die from this disease. Most cases of cervical cancer and all cases of genital warts are caused by human papillomavirus (HPV). The HPV vaccine, Gardasil , protects against the types of HPV that most commonly cause cervical cancer and genital warts.
HPV Vaccine Safety
- Questions and answers about HPV Vaccine Safety
- Reports to the Vaccine Adverse Events Reporting System (VAERS) Following HPV Vaccination (Updated September 1, 2009)
- JAMA Report Summary on HPV
- To Report an Adverse Event in VAERS
- Information from FDA and CDC on Gardasil and its Safety (Archived)
Related Scientific Articles
Slade BA, Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland A, Izurieta HS, Ball R, Miller N, Braun MM, Markowitz LE, Iskander J. Postlicensure Safety Surveillance for Quadrivalent Human Papillomavirus Recombinant Vaccine. JAMA. 2009 Aug 19;302(7):750-7.
CDC. Quadrivalent Human Papillomavirus Vaccine Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR. 2007 / Vol. 56 / RR-2.
Get email updates
To receive email updates about this page, enter your email address:
Contact Us:
- Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 - 800-CDC-INFO
(800-232-4636)
TTY: (888) 232-6348
24 Hours/Every Day - cdcinfo@cdc.gov


